|
|
| Model Number |
N/A |
| Medical Device Problem Code |
Defective Component (2292)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/20/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
As reported, a 7f exoseal vascular closure device did not change color during withdrawal.The device was withdrawn from the body and manual compression was used to achieve hemostasis.There was no reported patient injury.There was no difficulty connecting the vascular sheath introducer with the exoseal vascular closure device (vcd).The indicator wire cowling locked against the handle assembly and an audible click was heard.Pulsatile flow was observed from the bleed-back indicator.The exoseal vcd and vascular sheath introducer were retracted together until bleed back significantly slowed or stopped.The indicator did not show black-black.The physician did not have their thumb on the plug deployment button during retraction.The indicator window did not show red during retraction.When the device was removed from the patient, the indicator wire loop was deployed/visible, and no anomalies were noted to the loop.The device was not attempted to be deployed outside the patient's body.Femoral artery suitability was verified on angiography, including the 30-45 degree insertion angle of the vascular sheath introducer.The vessel diameter was verified to be greater than or equal to 5 mm.There was no visible calcium/plaque at the puncture site, no access vessel tortuosity, no stent near the puncture site, and no stenosis greater than 50% at or near the puncture site.The target femoral site had not been previously closed with a closure device or manual compression less than thirty days before the procedure.There was no evidence of pre-existing hematoma, arteriovenous fistula, or pseudoaneurysm at the access site prior to exoseal vcd use.The exoseal vcd was used in an interventional procedure using a retrograde approach.The patient's body mass index was not greater than 40.The physician had achieved certification on the use of exoseal vcd.There were no visible signs of device or package damage prior to use.The device was stored and prepared according to the instructions for use (ifu).The device will be returned for evaluation.
|
| |
|
Additional Manufacturer Narrative
|
|
Due to system limitations, section h6 required to input type of investigation, investigation findings, and investigation conclusions for an initial report.Pending additional information to complete investigation.This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
|
| |
|
Search Alerts/Recalls
|
|
|